Nicotinamide mononucleotide: Difference between revisions
| No edit summary |  Marked this version for translation | ||
| (One intermediate revision by the same user not shown) | |||
| Line 1: | Line 1: | ||
| <languages /> | |||
| <translate> | |||
| <!--T:1--> | |||
| {{Chembox | {{Chembox | ||
| <!-- Images --> | <!-- Images --> | ||
| Line 39: | Line 42: | ||
| }} | }} | ||
| <!--T:2--> | |||
| '''Nicotinamide mononucleotide''' ("'''NMN'''" and "'''β-NMN'''") is a [[nucleotide]] derived from [[ribose]], [[nicotinamide]], [[nicotinamide riboside]] and [[Niacin (substance)|niacin]]. In humans, several enzymes use NMN to generate [[nicotinamide adenine dinucleotide]] (NADH). In mice, it has been proposed that NMN is absorbed via the small intestine within 10 minutes of oral uptake and converted to nicotinamide adenine dinucleotide ([[Nicotinamide adenine dinucleotide|NAD+]]) through the [[SLC12A8|Slc12a8]] transporter. and the matter remains unsettled. | '''Nicotinamide mononucleotide''' ("'''NMN'''" and "'''β-NMN'''") is a [[nucleotide]] derived from [[ribose]], [[nicotinamide]], [[nicotinamide riboside]] and [[Niacin (substance)|niacin]]. In humans, several enzymes use NMN to generate [[nicotinamide adenine dinucleotide]] (NADH). In mice, it has been proposed that NMN is absorbed via the small intestine within 10 minutes of oral uptake and converted to nicotinamide adenine dinucleotide ([[Nicotinamide adenine dinucleotide|NAD+]]) through the [[SLC12A8|Slc12a8]] transporter. and the matter remains unsettled. | ||
| <!--T:3--> | |||
| Because NADH is a [[Cofactor (biochemistry)|cofactor]] for processes inside [[mitochondria]], for [[sirtuin]]s and [[Poly (ADP-ribose) polymerase|PARP]], NMN has been studied in [[animal model]]s as a potential neuroprotective and [[anti-aging]] agent. The reversal of aging at the cellular level by inhibiting [[mitochondrial decay]] in presence of increased levels of NAD+ makes it popular among anti-aging products. Dietary supplement companies have [[Hard sell|aggressively marketed]] NMN products, claiming those benefits. However, no human studies to date have properly proven its anti-aging effects with proposed health benefits only suggested through research done [[in vitro]] or through [[Animal testing|animal models]]. Single-dose administration of up to 500 mg was shown safe in men in a study at [[Keio University]]. One 2021 clinical trial found that NMN improved muscular insulin sensitivity in prediabetic women, while another found that it improved aerobic capacity in amateur runners. A 2023 clinical trial showed that NMN improves performance on a six-minute walking test and a subjective general health assessment. | Because NADH is a [[Cofactor (biochemistry)|cofactor]] for processes inside [[mitochondria]], for [[sirtuin]]s and [[Poly (ADP-ribose) polymerase|PARP]], NMN has been studied in [[animal model]]s as a potential neuroprotective and [[anti-aging]] agent. The reversal of aging at the cellular level by inhibiting [[mitochondrial decay]] in presence of increased levels of NAD+ makes it popular among anti-aging products. Dietary supplement companies have [[Hard sell|aggressively marketed]] NMN products, claiming those benefits. However, no human studies to date have properly proven its anti-aging effects with proposed health benefits only suggested through research done [[in vitro]] or through [[Animal testing|animal models]]. Single-dose administration of up to 500 mg was shown safe in men in a study at [[Keio University]]. One 2021 clinical trial found that NMN improved muscular insulin sensitivity in prediabetic women, while another found that it improved aerobic capacity in amateur runners. A 2023 clinical trial showed that NMN improves performance on a six-minute walking test and a subjective general health assessment. | ||
| <!--T:4--> | |||
| NMN is vulnerable to extracellular degradation by [[CD38]] enzyme, which can be inhibited by compounds such as [[CD38-IN-78c]]. | NMN is vulnerable to extracellular degradation by [[CD38]] enzyme, which can be inhibited by compounds such as [[CD38-IN-78c]]. | ||
| == Dietary sources == | == Dietary sources == <!--T:5--> | ||
| NMN is found in fruits and vegetables such as [[edamame]], [[broccoli]], [[cabbage]], [[cucumber]] and [[avocado]] at a concentration of about 1 mg per 100g, making these natural sources impractical to acquire the quantities needed to accomplish the dosing currently being investigated for NMN as a pharmaceutical. | NMN is found in fruits and vegetables such as [[edamame]], [[broccoli]], [[cabbage]], [[cucumber]] and [[avocado]] at a concentration of about 1 mg per 100g, making these natural sources impractical to acquire the quantities needed to accomplish the dosing currently being investigated for NMN as a pharmaceutical. | ||
| == Production == | == Production == <!--T:6--> | ||
| Production of nicotinamide mononucleotide has been redacted since the latter half of 2022 by the [[Food and Drug Administration|FDA]] because it is under investigation as a pharmaceutical drug. | Production of nicotinamide mononucleotide has been redacted since the latter half of 2022 by the [[Food and Drug Administration|FDA]] because it is under investigation as a pharmaceutical drug. | ||
| == Different expressions of NMN across human organs == | == Different expressions of NMN across human organs == <!--T:7--> | ||
| The synthesizing enzymes and consumption enzymes of NMN also exhibit tissue specificity: NMN is widely distributed in tissues and organs throughout the body and has been present in various cells since embryonic development. | The synthesizing enzymes and consumption enzymes of NMN also exhibit tissue specificity: NMN is widely distributed in tissues and organs throughout the body and has been present in various cells since embryonic development. | ||
| ==Potential benefits and risks== | ==Potential benefits and risks== <!--T:8--> | ||
| <!--T:9--> | |||
| NMN is a precursor for [[Nicotinamide adenine dinucleotide|NAD<sup>+</sup>]] biosynthesis, and NMN dietary supplementation has been demonstrated to increase NAD<sup>+</sup> concentration and thus has the potential to mitigate aging-related disorders such as [[oxidative stress]], [[DNA damage (naturally occurring)|DNA damage]], [[Neurodegenerative disease|neurodegeneration]] and [[inflammation|inflammatory responses]]. Song Q, Zhou X, Xu K, Liu S, Zhu X, Yang J. The Safety and Antiaging Effects of Nicotinamide Mononucleotide in Human Clinical Trials: an Update. Adv Nutr. 2023 Nov;14(6):1416-1435. doi: 10.1016/j.advnut.2023.08.008. Epub 2023 Aug 22. PMID: 37619764; PMCID: PMC10721522</ref> The potential benefits and risks of NMN supplementation, as of 2023, are currently under investigation. | NMN is a precursor for [[Nicotinamide adenine dinucleotide|NAD<sup>+</sup>]] biosynthesis, and NMN dietary supplementation has been demonstrated to increase NAD<sup>+</sup> concentration and thus has the potential to mitigate aging-related disorders such as [[oxidative stress]], [[DNA damage (naturally occurring)|DNA damage]], [[Neurodegenerative disease|neurodegeneration]] and [[inflammation|inflammatory responses]]. Song Q, Zhou X, Xu K, Liu S, Zhu X, Yang J. The Safety and Antiaging Effects of Nicotinamide Mononucleotide in Human Clinical Trials: an Update. Adv Nutr. 2023 Nov;14(6):1416-1435. doi: 10.1016/j.advnut.2023.08.008. Epub 2023 Aug 22. PMID: 37619764; PMCID: PMC10721522</ref> The potential benefits and risks of NMN supplementation, as of 2023, are currently under investigation. | ||
| <!--T:10--> | |||
| Certain enzymes are sensitive to the intracellular NMN/[[Nicotinamide adenine dinucleotide|NAD<sup>+</sup>]] ratio, such as [[SARM1]], a protein responsible for initiating cellular degeneration pathways such as [[MAP kinase]] and inducing [[axon|axonal]] loss and [[necrosis|neuronal death]]. [[NMNAT1|NMNAT]] is an enzyme with neurorescuing properties that functions to deplete NMN and produce NAD<sup>+</sup>, attenuating SARM1 activity and aiding neuronal survival ''in-vitro'', an effect that is reversed by applying exogenous NMN which promptly resumed axon destruction. The similar molecule nicotinic acid mononucleotide (NaMN) opposes the activating effect of NMN on [[SARM1]], and is a neuroprotector. | Certain enzymes are sensitive to the intracellular NMN/[[Nicotinamide adenine dinucleotide|NAD<sup>+</sup>]] ratio, such as [[SARM1]], a protein responsible for initiating cellular degeneration pathways such as [[MAP kinase]] and inducing [[axon|axonal]] loss and [[necrosis|neuronal death]]. [[NMNAT1|NMNAT]] is an enzyme with neurorescuing properties that functions to deplete NMN and produce NAD<sup>+</sup>, attenuating SARM1 activity and aiding neuronal survival ''in-vitro'', an effect that is reversed by applying exogenous NMN which promptly resumed axon destruction. The similar molecule nicotinic acid mononucleotide (NaMN) opposes the activating effect of NMN on [[SARM1]], and is a neuroprotector. | ||
| <!--T:11--> | |||
| {{二次利用|date=5 April 2024}} | {{二次利用|date=5 April 2024}} | ||
| [[Category:Nucleotides]] | [[Category:Nucleotides]] | ||
| Line 65: | Line 74: | ||
| [[Category:Nicotinamides]] | [[Category:Nicotinamides]] | ||
| [[Category:Anti-aging substances]] | [[Category:Anti-aging substances]] | ||
| </translate> | |||